Table 5.
Risk of death (OR and 95% CI) in COVID-19 patients with COPD versus those without COPD adjusted by covariates in several models of logistic regression multivariate analyses.
| Model 1 | Model 2 | Model 2 | |||
|---|---|---|---|---|---|
| COPD | 1.70 (1.29–2.23) | COPD | 1.52 (1.15–2.00) | COPD | 1.42 (1.07–1.88) |
| Sex | 1.86 (1.53–2.26) | Sex | 1.87 (1.54–2.28) | Sex | 1.82 (1.49–2.22) |
| Age | 1.06 (1.05–1.07) | Age | 1.05 (1.04–1.06) | Age | 1.05 (1.04–1.06) |
| HF | 1.65 (1.33–2.03) | Heart failure | 1.46 (1.17–1.81) | ||
| HBP | 1.59 (1.24–2.04) | HBP | 1.43 (1.10–1.84) | ||
| Stroke | 1.02 (0.78–1.32) | ||||
| Arrythmia | 1.30 (1.01–1.71) | ||||
| IHD | 1.05 (0.81–1.36) | ||||
| Diabetes | 1.23 (1.01–1.50) | ||||
| HL | 1.03 (0.81–1.31) | ||||
| Sleep apnoea | 1.27 (0.85–1.90) | ||||
| PTE | 1.72 (1.08–2.75) | ||||
| Smoking | 1.31 (0.99–1.71) |
Reference values are female sex and no comorbidity. Age is a continuous variable increasing in years; HF: Heart failure; HBP: High blood pressure; IHD: Ischemic heart disease; HL: Hyperlipidemia; PTE: Pulmonary thromboembolism.